Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anne Boccuti"'
Autor:
Raj Hanvesakul, Badri Rengarajan, Navit Naveh, Anne Boccuti, Julie E Park, Adekemi Adeyemi, Clyde Caisip, Jeroen P Jansen, Florence R Wilson
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 5 (2023)
Aim: Compare lurbinectedin versus other second-line (2L) small-cell lung cancer (SCLC) treatments. Methods: An unanchored matching-adjusted indirect comparison connected the platinum-sensitive SCLC cohort of a single-arm lurbinectedin trial to a ne
Externí odkaz:
https://doaj.org/article/402de053a3ce47b2bcc73a0d834d1e7e
Autor:
Apar Kishor Ganti, Patricia Prince, Xue Wang, Adina Estrin, Anne Boccuti, Badri Rengarajan, Navit Naveh, Ralph D'Agostino, Trevor Alvord, Rami Ben-Joseph
Publikováno v:
Journal of Clinical Oncology. 40:e20619-e20619
e20619 Background: Lurbinectedin monotherapy is currently approved for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy based on the results of a single-arm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42accf6a784144d1c7b3817eb7b6eb37
https://doi.org/10.1200/jco.2022.40.16_suppl.e20619
https://doi.org/10.1200/jco.2022.40.16_suppl.e20619
Autor:
Dylan Supina, Badri Rengarajan, Moshe Fridman, Raj Hanvesakul, Benjamin Taylor, Patricia Prince, Anne Boccuti, Adina Estrin, Kobby Asubonteng, Rami Ben-Joseph
Publikováno v:
Journal of Clinical Oncology. 39:e20577-e20577
e20577 Background: Previous studies have investigated overall survival (OS) among small cell lung cancer (SCLC) patients with data through 2015. Using data through mid-2019, this study strives to make the body of studies more current, and to provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3789e1cd9a181fe4a6aa0b7d646f02dc
https://doi.org/10.1200/jco.2021.39.15_suppl.e20577
https://doi.org/10.1200/jco.2021.39.15_suppl.e20577
Autor:
Benjamin Taylor, Kobby Asubonteng, Anne Boccuti, Adina Estrin, Rami Ben-Joseph, Raj Hanvesakul, Badri Rengarajan, Moshe Fridman, Patricia Prince, Dylan Supina
Publikováno v:
Journal of Clinical Oncology. 39:e20576-e20576
e20576 Background: With emerging treatment options for small-cell lung cancer (SCLC) patients after initial treatment failure, the real-world management of this disease should be assessed. This study aims to describe treatment patterns of real-world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab43deddbe452912d57a97221913b1fd
https://doi.org/10.1200/jco.2021.39.15_suppl.e20576
https://doi.org/10.1200/jco.2021.39.15_suppl.e20576
Autor:
Anne Boccuti, Marlise R. Luskin, Selina M. Luger, Robert Daber, Martin Carroll, Alison R. Sehgal, Phyllis A. Gimotty, Jianhua Zhao, Adam Bagg, Jennifer J.D. Morrissette, Caroline E. Sloan
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 4, p e0153016 (2016)
PLoS ONE, Vol 11, Iss 4, p e0153016 (2016)
BACKGROUND:Although cytogenetics-based prognostication systems are well described in acute myeloid leukemia (AML), overall survival (OS) remains highly variable within risk groups. An integrated genetic prognostic (IGP) model using cytogenetics plus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35d07f24f0513d8d85dbb45582b9287
http://europepmc.org/articles/PMC4822876
http://europepmc.org/articles/PMC4822876
Autor:
Martin Carroll, Selina M. Luger, Robert Daber, Jianhua Zhao, Phyllis A. Gimotty, Jennifer J.D. Morrissette, Caroline E. Sloan, Alison R. Sehgal, Adam Bagg, Anne Boccuti
Publikováno v:
Blood. 124:1032-1032
Background: Cytogenetics-based prognostication systems are well described in acute myeloid leukemia (AML). In younger patients ( Methods: We conducted a retrospective study of 2 cohorts of patients with newly diagnosed de novo AML for whom clinical,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f736f00317a9004d000f530c2610d38
https://doi.org/10.1182/blood.v124.21.1032.1032
https://doi.org/10.1182/blood.v124.21.1032.1032
Autor:
Jianhua Zhao, Selina M. Luger, Phyllis A. Gimotty, Robert Daber, Caroline E. Sloan, Alison R. Sehgal, Anne Boccuti, Jennifer J.D. Morrissette, Martin Carroll, Adam Bagg
Publikováno v:
Journal of Clinical Oncology. 32:7068-7068
7068 Background: Although cytogenetics-based prognostication systems are well described in acute myeloid leukemia (AML), Patel et al. (NEJM 2012) recently used data from patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a5203f7ef32ffe5e5bb99a3cb89e7ba
https://doi.org/10.1200/jco.2014.32.15_suppl.7068
https://doi.org/10.1200/jco.2014.32.15_suppl.7068
Autor:
Elaine Y. Chiang, Phyllis A. Gimotty, Rolando Vega, William H. Matthai, Anne Boccuti, Patrick F. Fogarty
Publikováno v:
Blood. 122:2354-2354
Introduction Information is limited regarding in-hospital management of ACS, which typically requires invasive procedures and/or exposure to antithrombotic agents, when complicated by the most common inherited bleeding disorder, VWD. We sought to ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2e6cff9ceb8185457b302f2b128b087
https://doi.org/10.1182/blood.v122.21.2354.2354
https://doi.org/10.1182/blood.v122.21.2354.2354